A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes
Authors
Keywords
Metformin, Pharmacogenetics, Type 2 diabetes mellitus, Calpain 10
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 71, Issue 1, Pages 59-63
Publisher
Springer Nature
Online
2014-10-20
DOI
10.1007/s00228-014-1774-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia
- (2012) Matthew A. Smith et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
- (2012) S L Stocker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control
- (2012) J. A. Hirst et al. DIABETES CARE
- Pharmacogenomic association between a variant inSLC47A1gene and therapeutic response to metformin in type 2 diabetes
- (2012) I. Tkáč et al. DIABETES OBESITY & METABOLISM
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
- (2012) NATURE GENETICS
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
- (2010) K. A. Jablonski et al. DIABETES
- An energetic tale of AMPK-independent effects of metformin
- (2010) Russell A. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
- (2009) Adriaan Kooy et al. ARCHIVES OF INTERNAL MEDICINE
- Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
- (2009) M. L. Becker et al. DIABETES
- Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
- (2009) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Calpain-10 Expression Is Elevated in Pancreatic Islets from Patients with Type 2 Diabetes
- (2009) Charlotte Ling et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started